title: Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery.
abstract: BACKGROUND
  Noncardiac surgery performed after coronary stent implantation is associated with an increased risk of stent thrombosis, myocardial infarction, and death. The influence of stent type and period of risk still have to be defined.
  
  
  RESULTS
  We linked the Scottish Coronary Revascularisation Register with hospital admission data to undertake a Scotland-wide retrospective cohort study examining cardiac outcomes in all patients who received drug-eluting or bare-metal stents between April 2003 and March 2007 and subsequently underwent noncardiac surgery. Of 1953 patients, 570 (29%) were treated with at least 1 drug-eluting stent and 1383 (71%) with bare-metal stents only. There were no differences between drug-eluting and bare-metal stents in the primary end point of in-hospital mortality or ischemic cardiac events (14.6% versus 13.3%; P=0.3) or the secondary end points of in-hospital mortality (0.7% versus 0.6%; P=0.8) and acute myocardial infarction (1.2% versus 0.7%; P=0.3). Perioperative death and ischemic cardiac events occurred more frequently when surgery was performed within 42 days of stent implantation (42.4% versus 12.8% beyond 42 days; P<0.001), especially in patients revascularized after an acute coronary syndrome (65% versus 32%; P=0.037). There were no temporal differences in outcomes between the drug-eluting and bare-metal stent groups.
  
  
  CONCLUSIONS
  Patients undergoing noncardiac surgery after recent coronary stent implantation are at increased risk of perioperative myocardial ischemia, myocardial infarction, and death, particularly after an acute coronary syndrome. For at least 2 years after percutaneous coronary intervention, cardiac outcomes after noncardiac surgery are similar for both drug-eluting and bare-metal stents.
authors.affiliation: Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom. nick.cruden@ed.ac.uk
authors.forename: Nicholas L M
authors.initials: NL
authors.lastname: Cruden
authors.forename: Scott A
authors.initials: SA
authors.lastname: Harding
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Flapan
authors.forename: Cat
authors.initials: C
authors.lastname: Graham
authors.forename: Sarah H
authors.initials: SH
authors.lastname: Wild
authors.forename: Rachel
authors.initials: R
authors.lastname: Slack
authors.forename: Jill P
authors.initials: JP
authors.lastname: Pell
authors.forename: David E
authors.initials: DE
authors.lastname: Newby
mesh_terms: D054855:Drug-Eluting Stents / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D007431:Intraoperative Complications; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000453:epidemiology / Q000209:etiology*; D019919:Prosthesis Implantation / Q000401:mortality / Q000706:statistics & numerical data; D012042:Registries; D012189:Retrospective Studies; D012307:Risk Factors; D012606:Scotland; D013514:Surgical Procedures, Operative / Q000401:mortality / Q000706:statistics & numerical data; D016019:Survival Analysis; D013927:Thrombosis / Q000453:epidemiology / Q000209:etiology*